Publications by authors named "Ken Yajima"

Claim this Profile
A
A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
Yuki Kobayashi, Takeya Adachi, Hiroki Arakawa, Yugo Minakata, Ken Yajima

J Dermatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report.
Yasuharu Kurokawa, Yoichi Oikawa, Akira Shimada, Ken Yajima

Diabetol Int· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient.
Ken Yajima, Yushi Akise

Case Rep Endocrinol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First case report of thyroid abscess caused by Helicobacter cinaedi presenting with thyroid storm.
Tomohiro Takehara, Tetsuo Tani, Ken Yajima, Mako Watanabe, Yoshihito Otsuka

BMC Infect Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T cell-dominant insulitis in acute-onset Type 1 diabetes mellitus associated with intraductal papillary mucinous adenoma.
Ken Yajima, Yoichi Oikawa, Kentaro Ogata, Akinori Hashiguchi, Akira Shimada

Endocr J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes.
Kumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, Masami Tanaka, Shu Meguro, Ken Yajima

Endocr J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A questionnaire survey on current status of anti-diabetic therapy for diabetic patients with dementia].
Takaya Matsushita, Ken Yajima, Hidetaka Sumitomo, Masayuki Shigeta, Kazuhiro Nishimura

Nihon Ronen Igakkai Zasshi· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-minute mental status examination for category fluency is more useful than mini-mental state examination to evaluate the reliability of insulin self-injection in elderly diabetic patients.
Ken Yajima, Takaya Matsushita, Hidetaka Sumitomo, Hirofumi Sakurai, Takashi Katayama

J Diabetes Investig· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.
Ken Yajima, Akira Shimada, Hiroshi Hirose, Yoichi Oikawa, Satoru Yamada

Clin Drug Investig· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of combination therapy of a rapid-acting insulin secretagogue (glinide) with premixed insulin in type 2 diabetes mellitus.
Satoru Yamada, Mari Watanabe, Osamu Funae, Yoshihito Atsumi, Ryuji Suzuki, Ken Yajima

Intern Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.
Ken Yajima, Akira Shimada, Hiroshi Hirose, Akira Kasuga, Takao Saruta

Rev Diabet Stud· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
Ken Yajima, Hiroshi Hirose, Haruhisa Fujita, Yoshiko Seto, Hiroshi Fujita

Am J Physiol Endocrinol Metab· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis